Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, +19

OncoImmunology

Surgical OncologyImmunologyGpc3 ExpressionPathologyPhase Ii Study +17

A glypican-3-derived peptide vaccine against hepatocellular carcinoma

Yu Sawada, Mayuko Sakai, Toshiaki Yoshikawa, +2

OncoImmunology

MedicineHepatobiliary TumorImmunologyPathologyTherapeutic Vaccine +9

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma

Kazuya Ofuji, Keigo Saito, Shiro Suzuki, +14

Oncotarget

Tumor BiologyHcc RecurrenceSurgical OncologyHepatologyRecurrence Patients +12

Pembrolizumab-induced autoimmune side effects of colon and pancreas in a patient with lung cancer

Kazuya Ofuji, Katsushi Hiramatsu, Takuto Nosaka, +7

Clinical Journal of Gastroenterology

Pancreatic CancerAutoimmune DiseaseMedicineImmunologyColorectal Cancer +6

A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer

Kazuya Ofuji, Yoshitaka Tada, Toshiaki Yoshikawa, +5

International Journal of Oncology

Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma

Kazuto Takahashi, Kazuya Ofuji, Katsushi Hiramatsu, +8

Cancer Medicine

A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype

Yoshihiko Ozaki, Hiroyuki Suto, Takuto Nosaka, +10

Clinical Journal of Gastroenterology

Intestinal PhenotypeGastrointestinal OncologyGastroenterologyPathologyClinical Gastroenterology +2

Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report

Tomoko Tanaka, Katsushi Hiramatsu, Takuto Nosaka, +11

BMC Cancer

Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages

Takuto Nosaka, Y. Murata, Kazuto Takahashi, +8

Biomedicine & Pharmacotherapy

Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents

Hidetaka Matsuda, Katsushi Hiramatsu, Yu Akazawa, +13

Journal of Medical Virology